TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T00070 XX ID T00070 XX DT 15.10.1992 (created); ewi. DT 10.04.2015 (updated); jtr. CO Copyright (C), QIAGEN. XX FA Pax-5 XX SY B-cell specific activator protein; BSAP; BSAP/PAX-5, B-cell Specific Activating Protein; hPax-5; hPax5; Pax-5; PAX5. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G003921 PAX5; HGNC: PAX5. XX HO TSAP (sea urchin). XX CL C0017; paired; 3.2.2.2.2. XX SF 5 possible isoforms exists [11]; SF intact paired domain required for recognition of all Pax-5 binding sites [3]; SF a C-terminally truncated paired domain recognizes a subset of sites [3]; SF crystal structure of Pax-5/DNA and of ternary complex Pax-5/c-Ets-1/DNA has been solved [8]; SF beta-hairpin and helix B of N-terminal domain are involved in direct contact with c-Ets-1 [8]; XX CP (pro-, pre-, mature B cells), astrocytic tumors [5]; tonsillar B cells (germinal centers and mantle zone) [12]. EX tonsil,B-lymphocyte,,adult; detectable; Northern blot; RNA (undefined); [12]. XX FF activator [6]; FF regulator of B cell development [2]; FF tumor initiation by inhibiting the p53 transcription [5]; FF acts synergistically and directly interacts with c-Ets-1 [6] [7]; XX IN T09205 Id3; human, Homo sapiens. XX MX M00143 V$PAX5_01. MX M00144 V$PAX5_02. MX M04064 V$PAX5_05. MX M04754 V$PAX5_06. MX M04765 V$PAX5_07. MX M07223 V$PAX5_11. MX M03577 V$PAX5_Q6. MX M00808 V$PAX_Q6. XX BS R37605. BS R57913. BS R04285. BS R04286. BS R38866. BS R35731. BS R67123. BS R67139. BS R67140. BS R67141. BS R24137. BS R24138. BS R71687. BS R37548. BS R39327. BS R29684. BS R41906. BS R38791. BS R13323. BS R28953. BS R37616. BS R37617. BS R04583. BS R04584. BS R01666. BS R01667. BS R01662. BS R01663. XX DR TRANSPATH: MO000024683. DR TRANSCOMPEL: C00239. DR UniProtKB: Q02548; XX RN [1]; RE0002744. RX PUBMED: 2116362. RA Barberis A., Widenhorn K., Vitelli L., Busslinger M. RT A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation RL Genes Dev. 4:849-859 (1990). RN [2]; RE0003103. RX PUBMED: 1375324. RA Kozmik Z., Wang S., Doerfler P., Adams B., Busslinger M. RT The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP RL Mol. Cell. Biol. 12:2662-2672 (1992). RN [3]; RE0003116. RX PUBMED: 8406007. RA Czerny T., Schaffner G., Busslinger M. RT DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site RL Genes Dev. 7:2048-2061 (1993). RN [4]; RE0004279. RX PUBMED: 1516825. RA Adams B., Doerfler P., Aguzzi A., Kozmik Z., Urbanek P., Maurer-Fogy I., Busslinger M. RT Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis RL Genes Dev. 6:1589-1607 (1992). RN [5]; RE0011183. RX PUBMED: 8521821. RA Stuart E. T., Haffner R., Oren M., Gruss P. RT Loss of p53 function through PAX-mediated transcriptional repression RL EMBO J. 14:5638-5645 (1995). RN [6]; RE0016685. RX PUBMED: 8804314. RA Fitzsimmons D., Hodsdon W., Wheat W., Maira S. M., Wasylyk B., Hagman J. RT Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. RL Genes Dev. 10:2198-2211 (1996). RN [7]; RE0016687. RX PUBMED: 10022910. RA Wheat W., Fitzsimmons D., Lennox H., Krautkramer S. R., Gentile L. N., McIntosh L. P., Hagman J. RT The highly conserved beta-hairpin of the paired DNA-binding domain is required for assembly of Pax-Ets ternary complexes. RL Mol. Cell. Biol. 19:2231-2241 (1999). RN [8]; RE0023824. RX PUBMED: 11779502. RA Garvie C. W., Hagman J., Wolberger C. RT Structural studies of Ets-1/Pax5 complex formation on DNA. RL Mol. Cell 8:1267-1276 (2001). RN [9]; RE0042428. RX PUBMED: 11799127. RA Emelyanov A. V., Kovac C. R., Sepulveda M. A., Birshtein B. K. RT The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells RL J. Biol. Chem. 277:11156-64 (2002). RN [10]; RE0047963. RX PUBMED: 11134340. RA Roberts E. C., Deed R. W., Inoue T., Norton J. D., Sharrocks A. D. RT Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding. RL Mol. Cell. Biol. 21:524-533 (2001). RN [11]; RE0056170. RX PUBMED: 15385562. RA Robichaud G. A., Nardini M., Laflamme M., Cuperlovic-Culf M., Ouellette R. J. RT Human Pax-5 C-terminal isoforms possess distinct transactivation properties and are differentially modulated in normal and malignant B cells. RL J. Biol. Chem. 279:49956-49963 (2004). RN [12]; RE0035360. RX PUBMED: 12052884. RA Lin K. I., Angelin-Duclos C., Kuo T. C., Calame K. RT Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. RL Mol. Cell. Biol. 22:4771-4780 (2002). XX //